Kalos Management, Inc. Iovance Biotherapeutics, Inc. Transaction History

Kalos Management, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 10, 2021	SELL	$20.35 - $26.63 $171,957 - $225,023	-8,450 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$28.67 - $52.59 $8,601 - $15,777	300 Added 3.68%	8,450 $246,000
Q4 2019 Feb 13, 2020	BUY	$17.95 - $29.41 $146,292 - $239,691	8,150 New	8,150 $221,000
Q1 2019 May 15, 2019	SELL	$8.41 - $11.26 $85,361 - $114,289	-10,150 Closed	0 $0
Q4 2018 Feb 13, 2019	BUY	$7.51 - $11.93 $76,226 - $121,089	10,150 New	10,150 $93,000

343

247M

2.51M

3.5M

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $559M
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

Get notified when there are updates to the investment portfolio of Kalos Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Kalos Management, Inc. with notifications on news.